New hope for Tough-to-Treat blood cancer: experimental drug enters human testing

NCT ID NCT05079282

Recruiting now Disease control Sponsor: Ono Pharmaceutical Co. Ltd Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called ONO-4685 in people with T cell lymphoma that has returned or hasn't responded to previous treatments. Researchers will give increasing doses to 217 participants to find the safest amount and see how the body processes the drug. The main goals are to check for side effects and see if the drug shows any signs of fighting the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

City of Hope
RECRUITING

Duarte, California, 91010, United States
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States
Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
Hackensack University Medical Center - John Theurer Cancer Center
RECRUITING

Hackensack, New Jersey, 07601, United States
Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States
MD Anderson
RECRUITING

Houston, Texas, 77030, United States
Memorial Sloan-Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
New York-Presbyterian/Columbia University Irving Medical Center - Herbert Irving Comprehensive Cancer Center (HICCC)
RECRUITING

New York, New York, 10032, United States
Novant Health Presbyterian Medical Center
RECRUITING

Charlotte, North Carolina, 28204, United States
Oregon Health & Science University
RECRUITING

Portland, Oregon, 97239, United States
Roswell Park Cancer Institute
RECRUITING

Buffalo, New York, 14263, United States
Stanford Cancer Institute
RECRUITING

Palo Alto, California, 94304, United States
UT Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
University of Alabama at Birmingham
COMPLETED

Birmingham, Alabama, 35294, United States
University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center
RECRUITING

Orange, California, 92868, United States
University of Pennsylvania - Perelman Center
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Vanderbilt University - Ingram Cancer Center
RECRUITING

Nashville, Tennessee, 37232, United States
Washington University School of Medicine in St. Louis
RECRUITING

St Louis, Missouri, 63110, United States
Winship Cancer Institute of Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Yale Cancer Center
RECRUITING

New Haven, Connecticut, 06519, United States

Conditions

Explore the condition pages connected to this study.

RELAPSED OR REFRACTORY T CELL LYMPHOMA